	Current News


	Omnilux on TV 11th Feb 2009 Role of Mast cell in wound healing and Skin rejuvenation elucidated 11th Feb 2009 Omnilux Clear-U™ Hand- Held device recieves FDA approval 16th January 2009 Omnilux New-U™ Hand-Held device recieves FDA approval 6th March 2008 Omnilux Plus receives TGA approval 6th March 2008 Photo Therapeutics Ltd appoint Sigmacon Medical Products 5th Dec 2007 Omnilux system honoured 11th November 2007 Omnilux Medical Bulletin Issue 7 9th October 2007 Clinical Study adds weight to LED Therapy 3rd August 2007 Recent Photo Therapeutics webcast available to download 7th December 2006 Photo Therapeutics Ltd Publication list by indication 15th November 2006 Expand your product portfolio, Distributors wanted. 1st July 2006 Omniluxcombination phototherapy receives FDA clearance 20th March 2005 Omnilux plus receives FDA clearance 15th March 2005 Last Updated 11th February 2009 Registered in England No. 3475828 VAT No. GB719704226 Registered Office: Station House, Altrincham, Cheshire WA14 1EP © Photo Therapeutics Ltd 2005 all rights reserved

News

Omnilux on TV 11th Feb 2009

Omnilux recently appeared on the Oxygen network in the US, airing in January 2009. The piece featured Dr Glynis Ablon; recent author of “Combination 830 nm and 633 nm LED phototherapy shows promise in the treatment of recalcitrant psoriasis: preliminary findings” in Journal of Photomedicine and Laser surgery. Dr Ablon has also penned a number of articles in the Aesthetic Buyers guide, featuring Omnilux and has presented on LED technology at IMCAS, Paris and a number of US exhibitions.

Dr Ablon runs the Ablon skin Institute in Manhattan Beach California. Her Resume can be found at http://www.abloninstitute.com/ablon/about/resume.asp

Download the TV appearance here

Role of the Mast cell in wound healing and Skin rejuvenation elucidated 11th Feb 2009

Extract from Calderhead et al. One Mechanism Behind Led Phototherapy For Wound Healing And Skin Rejuvenation: Key Role Of The Mast Cell. Laser Therapy 17.3: 141-148. 2008

Near Infrared light at 830nm, delivered in continuous wave has previously been identified as an effective wavelength in the stimulation of inflammatory stage cells in the wound healing cycle, namely macrophages1 and leukocytes.

A recent study involving 8 healthy male subjects and 830 nm LED therapy has shown conclusive evidence of the role of LED therapy in skin rejuvenation. The volar aspect of the left forearm was irradiated once for 20 min (60 J/cm2) with a continuous wave 830 nm LED system (Omnilux® plus™, Photo Therapeutics Ltd, Fazeley, UK), the contralateral right forearm serving as an unirradiated control. Transmission electron microscopy (TEM) of specimens from the left arm at baseline and 48 hr post irradiation from both the left and right arms showed no difference in morphology. However, in the left post irradiation specimens, a mild inflammatory response was noted with highly statistically significant numbers of macrophages, leukocytes and mast cells compared with controls. The mast cells were all in the degranulation stage, having shed at least 50% of their granules into the surrounding normal tissue, 48 hr after the single irradiation with 830 nm. No such degranulation was noted in the contralateral control specimens.

To download the full manuscript click here (1.36MB)

Omnilux Clear-U^TM Hand-Held device recieves FDA approval 16th January 2009

Photo Therapeutics Ltd, is pleased to announce it has received FDA clearance (K081307) for its new over-the-counter light therapy device, Omnilux Clear-U. Omnilux Clear-U is indicated for the treatment of mild to moderateacne on the face.

Omnilux Clear-U has been clinically proven to treat acne vulgaris using a combination of alternate treatments of blue and red light twice a week for four weeks, click here (266KB) for full article

Omnilux New-U^TM Hand-Held device recieves FDA approval 6th March 2008

PhotoTherapeutics Ltd is pleased to announce it has received FDA approval on its new over the counter light therapy device, Omnilux New-U, for the treatment of periorbital wrinkles.

Omnilux New-U has been clinically proven to reduce periorbital wrinkles and to treat the visible signs of ageing, using a combination of alternate treatment of Infrared and red light twice a week for four weeks. click here (36KB) for full article

Omnilux Plus receives TGA approval 6th March 2008

PhotoTherapeutics are proud to announce that they have received TGA approval for Omnilux plus. Omnilux plus is the fourth treatment head in the Omnilux family to gain TGA approval.

Using near Infrared light at a wavelength of 830nm, Omnilux plus is indicated for skin rejuvenation and periorbital wrinkles, wound healing applications, pain management and psoriasis.

In combination with visible red light, clinical trials have indicated, statistically significant reduction in periorbital wrinkles and a reduction in healing time of 50% when used after ablative surgery.

“This is a significant milestone in the development of Omnilux technology in Australia” comments Sue D’Arcy CEO of Photo Therapeutics. “This wavelength; in combination with visible red light (Omnilux revive) will offer current Omnilux users a potent anti-ageing solution, with clinical trials demonstrating a significant improvement of periorbital wrinkles when compared with visible red light alone”

The Therapeutic Goods Administration (TGA) is a division of the Australian Department of Health and Ageing. Its principal role is as the national regulator of therapeutic goods - a collective term covering medicines, medical devices and some related products. The TGA administers the Therapeutic Goods Act 1989, the objects of which include 'a national system of controls relating to the quality, safety, efficacy and timely availability of therapeutic goods that are used in Australia, whether produced in Australia or elsewhere.

To find out more on the availability of Omnilux plus in Australia, please contact our registered distributor; True Solutions International; NSW 2017.

Phone: 61 2 8332 1818 or Toll Free: 1800 808 993.

www.true-solutions.com.au

Photo Therapeutics Ltd appoints Sigmacon Medical Products 5th Dec 2007

PhotoTherapeutics Ltd are pleased to announce the appointment of Sigmacon

Medical Products, as their exclusive distributor of Omnilux Medical in

Canada.

Sigmacon Medical Products is a Canadian distributor of new and emerging

healthcare technologies, including diagnostic equipment, light therapy systems and surgical lasers for ophthalmology, dermatology, otolaryngology, gynecology, phlebology and urology. Their speciality in developing successful sales and Marketing strategies in evolving markets makes them the ideal choice to partner with PhotoTherapeutics and the Omnilux Brand.

To find out more about Sigmacon and the range of products they offer,

visit www.sigmacon.com

Omnilux^TM system honoured 11th November 2007

Photo Therapeutics Inc. are happy to announce that it has been honoured with the “2006 Laser & Light Technology Choice Award” in the Best Non Laser Device for Acne Category for its Omnilux™ system.

The award, which is presented by Aesthetic Trends & Technologies magazine, recognizes notable technological innovations in cosmetic laser and light technology.

“We are honoured by this recognition and proud to represent the aesthetics industry as an innovator in non-laser procedures for acne,” said Sue D’Arcy, of PhotoTherapeutics, Inc. “The award further validates our position as the first choice LED system. The ideal of using the correct wavelength, intensity and dose of light has always been paramount, resulting in maximized patient outcome. The large number of clinical papers featuring our products should prove to those in the market for an LED device that there is no effective alternative, and that one should not consider unproven, low-powered devices, or those that claim mixed wavelengths as the way forward when the clinical evidence shows, quite clearly, that this is not the case.”

The awards are created to both recognize excellence in the industry, as well as to educate the industry on what aesthetic devices are available and recommended by peers in each category. Recipients were chosen based on product efficacy, cost, reliability, ease-of-use, patient comfort and product training.

Non-invasive methods of treating acne are fast becoming a preferred route for patients seeking optimal results with fewer side effects. Current treatment regimens are not without complications and the long-term effects of antibiotics are still being researched. Omnilux™ offers a highly effective, pain free, light-only treatment without the need to apply topical photosensitizers and the inherent problems associated with these. Independent clinical studies show an average clearance of between 78-81% of acne lesions following a 4 week course of alternate Omnilux blue and Omnilux revive light therapy. The therapy is well tolerated and patient satisfaction and compliance are significantly high.

To find out more about the awards log on to http://www.aesthetictrends.com/index.html

Omnilux Medical Bulletin Issue 7 9th October 2007

The latest issue of the Omnilux Medical Bulletin can be downloaded in PDF version by clicking here (312KB)

Expand your product portfolio, Distributors wanted for Germany. 31 August 2007

We are looking for companies to broaden our current distributor base, with a number of regions in Germany being vacant

If you distribute into either the Medical or aesthetic/cosmetic markets, cover regions or multiple regions in Germany and are looking to expand your product range we would like to hear from you. Omnilux™ can offer you and your clients an excellent return on investment and acts as a true market differentiator. Omnilux™ has proven peer reviewed publications to support its many applications and extensive clinical and luminary support.

Become part of the growing distributor network for the market leader in LED light therapy, Omnilux™ .

Photo Therapeutics offers innovative, effective and affordable solutions for the management of oncological and non-oncological conditions in the global medical market and are world leaders in light only aesthetic treatments, maximising our value to both customers, shareholders and employees.

Please send your company details to steve.baker@omnilux.co.uk

Clinical Study adds weight to LED Therapy 3rd August 2007

There has been a great deal of scepticism regarding the efficacy of Light emitting diode (LED) phototherapy in the rejuvenation of photo- and chronologically-aged skin, however recent work, by Drs Park & Lee, Department of Dermatology, National Medical Center, Seoul, Korea, using the Omnilux system (PhotoTherapeutics INC, Carlsbad, CA, USA) looks likely to have quashed much of this cynicism and help establish the mechanism of LED therapy in skin rejuvenation.

The study, involving 76 subjects, was a randomised, controlled, double-blinded clinical study to determine the clinical efficacy, and investigate histologic and ultrastructural changes, enzymatic alterations and changes in key cytokines after Omnilux therapy using two wavelengths, 830nm(Omnilux plus) and 633nm(Omnilux revive).

Subjects were split into 4 study groups, each receiving designated wavelength(s), delivered under a precise time regime in order to stimulate the cell lines involved in all phases of the wound healing process.

The abstract can be downloaded here (51KB)

IMCAS ASIA 2007 July 16th-17th 2007

IMCAS Asia, 16^th -17^th July 2007 held at the Millenium Hilton, Bangkok, will see Omnilux represented in 3 talks over the 2 days

Omnilux will appear in the following sessions:

Session 5. Monday 16^th July, 2pm “The importance of combination LED therapy in skin rejuvenation”

Teaching Course 1. Monday 16^th July, 4:30 pm “True photoantiageing with LED therapy

Teaching Course 8. Tuesday 17^th July, Time TBA “Photobiological basics of LED therapy

During the presentations the latest data from the Park and Lee study group (NMC, Korea) will be presented.

Photo Therapeutics Webcasts available to download 7th December 2006

Photo Therapeutics have recently hosted several webcasts with leading US dermatologists

"Omnilux: Fact not Fiction", David Goldberg MD was the first webcast that was presented and this was followed by "Omnilux in Practice", Mark Taylor MD. The latest webcast that was broadcast was "Non Invasive Light based treament " presented by Joe Niamtu III DMD. All 3 webcasts proved really popular, however if you missed any of these webcasts, they are now available to download

Please click here to register for access to our download area

--------------------------------------------------------------------------------------------------

Omnilux Medical Bulletin Issue 6 7th December 2006

The latest issue of the Omnilux Medical Bulletin can be downloaded in PDF version by clicking here (380KB)

--------------------------------------------------------------------------------------------------

Photo Therapeutics Ltd Publication list by indication 15th November 2006

The latest Publication list by indication from Photo Therapeutics can be from downloaded in PDF version by clicking here (101KB)

--------------------------------------------------------------------------------------------------

Expand your product portfolio, Distributors wanted. 1st July 2006

We are looking for companies to broaden our current distributor base.

If you distribute into either the Medical or aesthetic/cosmetic markets and are looking to expand your product range we would like to hear from you. Omnilux^TM can offer you and your clients an excellent return on investment and acts as a true market differentiator. Omnilux^TM has proven peer reviewed publications to support its many applications and extensive clinical and luminary support.

Become part of the growing distributor network for the market leader in LED light therapy, Omnilux^TM .

Phototherapeutics offers innovative, effective and affordable solutions for the management of oncological and non-oncological conditions in the global medical market and are world leaders in light only aesthetic treatments, maximising our value to both customers, shareholders and employees.

Please send your company details to sales@omnilux.co.uk